Idiopathic pulmonary fibrosis: is all-cause mortality a practical and realistic end-point for clinical trials?
- PMID: 23345573
- DOI: 10.1136/thoraxjnl-2012-203114
Idiopathic pulmonary fibrosis: is all-cause mortality a practical and realistic end-point for clinical trials?
Comment on
-
Hot of the breath: mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good.Thorax. 2012 Nov;67(11):938-40. doi: 10.1136/thoraxjnl-2012-202580. Epub 2012 Oct 9. Thorax. 2012. PMID: 23047830 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical